Nuvectis Pharma Cash Flow Statement (2021) | NVCT

Cash Flow Statement Sep2021
Operating Activities
Share-based Compensation 0.14M
Cash from Operations -4.43M
Change in Working Capital
Change in Accured Expenses 0.11M
Financing Activities
Other financing activities 0.14M
Change in Capital Stock
Preferred Shares Issued 4.02M
Misc.
Cash from Financing Activities 4.02M
Change in Cash -0.41M
Beginning Cash Balance 0.41M
Free Cash Flow -4.43M
Net Cash Flow -0.41M